Unveiling the Screening Process for an Egg Donor: Ensuring the Perfect Match

Last reviewed: August 2026. Egg-donor screening is designed to evaluate medical safety, infectious-disease risk, genetic and family history, and informed readiness for donation. It cannot guarantee a pregnancy, a healthy child or a “perfect match.” The fertility clinic—not the matching platform or intended parents—determines whether a donor is medically eligible for a specific cycle.

Medical and reproductive evaluation

The clinic reviews the donor's personal and family medical history, prior pregnancies or donation cycles, medications and relevant health conditions. A reproductive evaluation may include ultrasound and ovarian-reserve testing to help the physician plan stimulation. Exact tests vary by clinic and individual circumstances.

Infectious-disease screening and testing

In the United States, donor eligibility includes FDA-regulated screening and testing for relevant communicable diseases. The required tests and timing depend on whether the donor is treated as an anonymous or directed donor and on current federal requirements. Clinics may perform additional testing beyond the federal minimum.

Genetic and family-history assessment

A detailed multigenerational family history can identify conditions that deserve further evaluation. Carrier screening may also be recommended. Genetic screening reduces some known risks but cannot rule out every genetic condition or predict all future health outcomes. When appropriate, a genetics professional can help interpret results and reproductive implications.

Psychological consultation

Professional guidance for gamete donation commonly includes psychoeducational or psychological assessment. Topics may include motivation, expectations, informed consent, family attitudes, the possibility of donor-conceived offspring, identity-release arrangements and future contact. The purpose should be informed and ethical participation, not simply to label someone as a “good” or “bad” donor.

Legal and consent considerations

Before retrieval, the donor should understand consent documents and any legal agreement covering compensation, expenses, use and disposition of eggs or embryos, confidentiality, identity-release terms and future medical-information updates. Independent legal advice may be appropriate, especially for known or directed donation.

Monitoring during ovarian stimulation

Once treatment begins, the clinic monitors the donor's response using ultrasound and, when indicated, blood tests. The frequency is individualized rather than automatically “every two days.” Medication doses and timing may change according to follicular development and hormone results.

Previous screening may need to be repeated

An experienced donor's old records can be useful, but prior clearance does not automatically qualify her for a new cycle. Infectious-disease testing has specific timing requirements, health histories change, and a new clinic may require updated medical, genetic or psychological information.

Questions intended parents can ask

• Who makes the donor's final medical-eligibility decision?
• Which screening has already been completed and when?
• What testing must be repeated before retrieval?
• Has the donor's family medical history been reviewed and updated?
• What carrier screening is recommended for the donor and sperm source?
• What identity-release or future-contact policy applies?
• How are important future medical updates handled?

Bottom line

Egg-donor screening is a risk-reduction and informed-consent process, not a guarantee of treatment success. Intended parents should confirm that the treating fertility clinic has completed the screening it requires for the specific donor and treatment plan.

This article provides general educational information and is not medical or legal advice.